Properly Manage the New Inhaled Levodopa (Inbrija) on Admission

Inbrija (in-BREE-jah) will be the first INHALED levodopa for adults with Parkinson's disease.

It's an on-demand levodopa that starts to work in about 10 minutes and lasts about an hour. It's used PRN to treat "off" episodes...when scheduled carbidopa/levodopa wears off between doses and symptoms return.

Patients will still need scheduled carbidopa/levodopa...and may also use add-ons, such as dopamine agonists (pramipexole, etc), MAO-B inhibitors (rasagiline, etc), or COMT inhibitors (entacapone, etc).

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals